Views
4 years ago

64 - D Cohen - Octubre 2010

  • Text
  • Serotonina
  • Opioides
  • Tlp
  • Personalidad
  • Psico
  • Trastorno
  • Opioide
  • Borderline
  • Pacientes
  • Relaciones
  • Personalidad
  • Receptor
  • Conductas
  • Psychiatry
  • Apego
Endofenotipos en el trastorno límite de la personalidad. Enfoque en la neurobiología del apego

Dr. Diego

Dr. Diego Cohen Referencias bibliográficas 1. Grant BF, Chou PS, Goldstein RB, Hunag B, Stinson FS, Saha DS. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2008;69(4):533-45. 2. American Psichiatric Association. Diagnostic and Statiscal Manual of Mental, Fourth Edition. Washington, DC: American Psychiatric Association; 1994. 3. Bradley R, Zittel Conklin J, Westen D. Borderline Personality Disorders. En: O´Donohue W, Fowler KA, Lilienfeld SO editores. Personality Disorders. Toward the DSM-V. Los Angeles: Sage Publications; 2007. p.167-201. 4. Gunderson JG. Borderline Personality Disorder. A Clinical Guide. Washington, DC: American Psychiatric Publishing;2001. 5. Gunderson JG. Disturbed relationships as a phenotype for borderline personality disorder. Am J Psychiatry 2007;164:1637-40. 6. Gabbard GO. Mind, Brain, and Personality Disorders. Am J Psychiatry 2005;162:648-55. 7) Cohen DE. Pautas para el tratamiento psicofarmacológico del transtorno límite de la personalidad (guías prácticas APA). Psicofarmacología 2009 55(9):10-7. 8. Stanley B, Siever LJ. The Interpersonal Dimension of Borderline Personality Disorder: Toward a Neuropeptide Model. Am J Psychiatry 2010;167:24-39. 9. Skodol AE, Siever LJ, Livesley WJ, Gunderson JG, Pfohl B, Widiger A.The Borderline Diagnosis II: Biology, Genetics, and Clinical Course. Biol Psychiatry 2002;51:951-63. 10. Siever LJ, Torgersen S, Gunderson JG, Livesley WJ, Kendler KS. The Borderline Diagnosis III: Identifying Endophenotypes for Genetic Studies. Biol Psychiatry 2002;51:964-8. 11. Cohen DE. Trastornos afectivos y trastorno límite de la personalidad: convergencias y divergencias. En: Zieher LM, Brió MC editores. Tratado de Psicofarmacología y Neurociencia. Vol II Parte I. Buenos Aires: Editorial Sciens;2010. p.153-80. 12. Gottesman II, Gould TD. The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions. Am J Psychiatry 2003;160:636-45. 13. Gunderson JG, Lyons-Ruth K. BPD`s Interpersonal Hypersensitivity Phenotipe: A- Gene-Enviriment-Developmental Model. J Personal Disord 2008;22(1):22-41. 14. Gunderson JG. The borderline patient´s intolerance of aloneness insecure attachment and therapist availability. Am J Psychiatry 1996;153:752-8. 15. owlby J. La pérdida afectiva. Tristeza y depresión. Buenos Aires: Paidós;1993. 16. Bowlby J. El apego y la pérdida – 1. El apego. Buenos Aires: Paidós;1998. 17. Panksepp J. Affective Neuroscience. The Foundations of Human and Animal Emotions. New York, Oxford: Oxford University Press;1998. 18. Insel T. A neurobiological basis of social attachment. Am J Psychiatry 1997;54:726-35. 19. Insel T, Winslow J. Serotonin and neuropeptides in affiliative behaviours. Biol Psychiatry 1998;44:207-19. 20. Insel T, Winslow J. The neurobiology of social attachment. in: neurobiology of mental illness. New York, Oxford: Oxford University Press;1999. p. 880-91. 21. Insel T, Young L. The neurobiology of attachment. Nat Rev Neurosci 2001;2:129-36. 22. Ainsworth M, Waters E y Wall S (1978). Patterns of attachment: a psychological study of the strange situation. Lawrence Erlbaum: New Jersey. 23. Lakatos K, Nemoda Z, Toth I, Ronai Z, Ney K, Sasvari-Szekely M et al. Further evidence for the role of the dopamine D4 receptor (DRD4) gene in attachment disorganization: interaction of the exon III 48-bp repeat the -521 C/T promoter polymorphisms.. Mol Psychiatry 2002;7(1):27-31. 24. Zieher LM. Actualización en la patofisiología de la esquizofrenia desde la perspectiva de la neurociencia de sistemas. En: Zieher LM, Brió MC editores. Tratado de Psicofarmacología y Neurociencia. Vol I. Buenos Aires: Editorial Sciens; 2009: p.73-88. 25. Agrawal HR, Gunderson JG, Holmes BM, Lyons-Ruth K. Attachment Studies with Bordeline Patients: A Review. Harv Rev Psychiatry 2004; 12(2):94-104. 26. Jang KL, Livesley WJ, Vernon PA, Jackson DN. Heritability of personality disorder traits: a twin study. Acta Med Scand Suppl 1996;94:438-44. 27. Kendler KS, Aggen SH, Czajkowski N, Roysamb E, Tambs K, Torgersen S et al. The Structure of Genetic and Environmental Risk Factors for DSM-IV Personality Disorders. Arch Gen Psychiatry 2008;65(12):1438-46. 28. New AS, Stanley B. An Opioid Deficit in Borderline Personality Disorder: Self-Cutting, Substance Abuse, and Social Dysfunction. Am J Psychiatry 2010;167:882-5. 29. Russ MJ, Shearin EN, Clarkin JF, Harrison K, Hull JW. Subtypes of Self-Injurious Patients With Borderline Personality Disorder. Am J Psychiatry 1993;150:1869-71. 30. Simeon D, Stanley B, Frances A, Mann JJ, Winchel R, Stanley M. Self-Mutilation in Personal Disorders: Psychological and Biological Correlates. Am J Psychiatry 1992;149:221-6. 31. Bohus M, Landwehrmeyer B, Stiglmary Ch, Limberger M, Bohme R, Schmal Ch. Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial. J Clin Psychiatry 1999 60: 598- 603. 32. Prossin AR, Love TM, Koeppe RA, Zubieta J- K, Silk KR. Dysregulation of Regional Endogenous Opioid Function in Borderline Personality Disorder. Am J Psychiatry 2010;167:925-33. 33. Maremmani I, Pacini, M Pani, P. Effectiveness of buprenorphine in double diagnosed patients.Buprenorphine as psychothropic drug. Heroin Add & Rel Clin Probl 2006;8:31- 48. 34. Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE. Genetic Sensitivity to the Environment: The Case of The Serotonin Transporter Gene and its Implications for Studying Complex Diseases and Traits. Am J Psychiatry 2010;167:509-27. 35. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW et al. Role of Genotype in the Cycle of Violence in Maltreated Children. Sci 2002;297:851-4. 36. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al. Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene. Sci 2003;301:386-9. 37. Hariri AR, Holmes A. Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Sci 2006;10(4):182-91. 38. Widiger TA, Mullins-Sweatt SN. Modelos categoriales y dimensionales de los trastornos de la personalidad. En: Oldman JM, Skodol AE, Bender DS editores. Tratado de los Trastornos de la Personalidad. Barcelona: Elsevier Masson;2007. p.37-55. 39. Gross C, Hen R. The Developmental Origins of Anxiety. Nature Rev Neurosci 2004;5:545-52. 40. Ni X, Chan K, Bulgin N, Sicard T, Bismil R, McMain Sh, Kennedy JL. Association between serotonin transporter gene and bordeline personality disorder. J Psychiatr Res 2006; 40:448-53. 41. New AS, Hazlett EA, Buchsbaum MS, Goodman M, Mitelman SA, Newmark R et al. Amygdala-Prefontal Disconnection in Borderline Personality Disorder. Neuropsycopharmacol 2007;32:1629-40. 42. Morris JS, Friston KJ, Büchel C, Frith CD, Young AW, Calder AJ et al. A neuromodulatory role for the human amygdala in processing emotional facial expressions. Nature 1998;383:812- 5. 43. Silbersweig D, Clarkin JF, Goldstein M, Kernberg OF, Tuescher O, Levy KN et al. Failure of frontolimbic inhibitory function in the context of negative emotion in borderline personality disorder. Am J Psychiatry 2007;164(12):1776-9. 44. Shmahl C, Douglas Bremmer J. Neuroimaging in borderline personality disorder. J Psychiatry Res 2006;40:419-27. 45. Francis D, Dorio J, Liu D, Meany MJ. Nongenomic Transmission Across Generations of Maternal Behavior and Stress Responses in the Rat. Sci 1999;286:1155-8. 16 // EDITORIAL SCIENS

Biblioteca

Av. García del Río 2585 Piso 12 A - C.A.B.A
+54 11 2092 1646 | info@sciens.com.ar

Editorial Sciens, Todos los Derechos Reservados 2015